Boehringer Ingelheim and Carebox Healthcare Solutions have launched a digital platform aimed at giving patients, families, caregivers and doctors the opportunity to learn ab
Boehringer Ingelheim has bought rights to preclinical technology aimed at fibro-inflammatory diseases including the fatty liver disease known as NASH, a prime target for many pharma compani
